+Follow
墨池思存
No personal profile
284
Follow
12
Followers
1
Topic
0
Badge
Posts
Hot
墨池思存
2020-11-02
?
The Federal Reserve is not expected to expand its bond purchases or shift to longer-term bonds this year and next
墨池思存
2020-11-02
?
Sorry, the original content has been removed
墨池思存
2020-10-23
?
Foreign media headlines: Remdesivir becomes the first drug approved for COVID-19 in the United States
Go to Tiger App to see more news
{"i18n":{"language":"en_US"},"userPageInfo":{"id":"3564397746531755","uuid":"3564397746531755","gmtCreate":1601303723631,"gmtModify":1607763392531,"name":"墨池思存","pinyin":"mcscmochisicun","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.tigerbbs.com/8a9df42be54916e8618a324eb2723690","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":12,"headSize":284,"tweetSize":55,"questionSize":0,"limitLevel":999,"accountStatus":2,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":1,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":2,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"1026c425416b44e0aac28c11a0848493-1","templateUuid":"1026c425416b44e0aac28c11a0848493","name":"Debut Tiger","description":"Join the tiger community for 500 days","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.04.26","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001}],"userBadgeCount":1,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":1,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":306978120,"gmtCreate":1604267765560,"gmtModify":1704955313038,"author":{"id":"3564397746531755","authorId":"3564397746531755","name":"墨池思存","avatar":"https://static.tigerbbs.com/8a9df42be54916e8618a324eb2723690","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3564397746531755","idStr":"3564397746531755"},"themes":[],"htmlText":"?","listText":"?","text":"?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/306978120","repostId":"2080604888","repostType":2,"repost":{"id":"2080604888","kind":"news","pubTimestamp":1604261466,"share":"https://ttm.financial/m/news/2080604888?lang=en_US&edition=fundamental","pubTime":"2020-11-02 04:11","market":"sh","language":"zh","title":"The Federal Reserve is not expected to expand its bond purchases or shift to longer-term bonds this year and next","url":"https://stock-news.laohu8.com/highlight/detail?id=2080604888","media":"新浪财经","summary":"彭博调查的经济学家大多认为，美联储今年或明年都不会加快资产购买速度，而即便美联储扩大购债，也不会对美国经济构成富有意义的提振。在这项调查中，59%的经济学家表示预计美联储不会在2021年底前提高购债规模，几乎没人预期11月会议上会有政策调整。在预计美联储将扩大购债规模的人当中，三分之二预计会是在2021年第一季度。相比之下，61%的人预期美联储将最终改变购买债券的期限分布，更偏重期限较长的债券。","content":"<p><html><body>Most economists surveyed by Bloomberg believe that the Fed will not speed up asset purchases this year or next year, and even if the Fed expands its bond purchases, it will not give a meaningful boost to the U.S. economy.</p><p>Many Fed watchers are hoping for more forward guidance on the central bank's balance sheet policy, but don't expect any new clues from the FOMC Nov. 4-5 meeting. After the September 15-16 meeting, the Fed further clarified the path of interest rates in the coming years, but there was no new guidance on whether it might change the size or pattern of the bond purchase program.</p><p>According to the survey conducted by Bloomberg on Oct. 23-29, 54% of respondents said the Fed has so far failed to \"adequately describe balance sheet policy and link it to economic goals.\"</p><p>\"Aside from strong forward guidance that Federal Funds rate will remain near zero for longer, monetary policy is now highly opaque,\" said Lynn Reaser, chief economist at Point Loma Nazarene University.</p><p>However, other respondents said it was unfair to expect new information from the Fed before the results of the US election were clear.</p><p>\"The Fed must observe the impact of the election on fiscal policy before making a decision,\" said Christopher Low, chief economist at FHN Financial.</p><p><div><img src=\"http://k.sinaimg.cn/n/finance/transform/664/w447h217/20201102/c21a-kcieyvz4277219.png/w720fin.jpg\"/></div>In the survey, 59% of economists said they did not expect the Fed to increase its bond purchases by the end of 2021, and few expected policy adjustments at the November meeting.</p><p>Bond Purchase Scheme</p><p>The Fed currently buys $80 billion in U.S. Treasury Bond and $40 billion in mortgage-backed securities each month to help the market run smoothly and put downward pressure on the borrowing rates that households and businesses bear.</p><p><div><img src=\"http://k.sinaimg.cn/n/finance/transform/721/w455h266/20201102/cdff-kcieyvz4277843.png/w720fin.jpg\"/></div>\"The baseline scenario assumes that the U.S. economy will stay on track and there is no need to increase purchases,\" said Roberto Perli, a partner at Cornerstone Macro. \"But if things get worse, I think the Fed will quickly increase its purchases.\"</p><p>Of those who expect the Fed to expand its bond purchases, two-thirds expect it to be in the first quarter of 2021.</p><p>When asked if the Fed would have a meaningful impact on the economy if it increased its debt purchases significantly, only 24% said so.</p><p>Economists strongly oppose the idea that the Fed could shift its buying mix more heavily toward Treasury Bond. In contrast, 61% expect the Fed to eventually change the maturity distribution of bond purchases in favor of longer-maturity bonds. Their current bond purchase operations are roughly balanced and spread across maturities.</p><p>Of the economists who expect the Fed to adjust the maturity of the bonds they buy, 79% expect it to be implemented in December or the first quarter of next year.</p><p></body></html></p>","source":"sina_symbol","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>The Federal Reserve is not expected to expand its bond purchases or shift to longer-term bonds this year and next</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThe Federal Reserve is not expected to expand its bond purchases or shift to longer-term bonds this year and next\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">新浪财经</strong><span class=\"h-time small\">2020-11-02 04:11</span>\n</p>\n</h4>\n</header>\n<article>\n<p><html><body>Most economists surveyed by Bloomberg believe that the Fed will not speed up asset purchases this year or next year, and even if the Fed expands its bond purchases, it will not give a meaningful boost to the U.S. economy.</p><p>Many Fed watchers are hoping for more forward guidance on the central bank's balance sheet policy, but don't expect any new clues from the FOMC Nov. 4-5 meeting. After the September 15-16 meeting, the Fed further clarified the path of interest rates in the coming years, but there was no new guidance on whether it might change the size or pattern of the bond purchase program.</p><p>According to the survey conducted by Bloomberg on Oct. 23-29, 54% of respondents said the Fed has so far failed to \"adequately describe balance sheet policy and link it to economic goals.\"</p><p>\"Aside from strong forward guidance that Federal Funds rate will remain near zero for longer, monetary policy is now highly opaque,\" said Lynn Reaser, chief economist at Point Loma Nazarene University.</p><p>However, other respondents said it was unfair to expect new information from the Fed before the results of the US election were clear.</p><p>\"The Fed must observe the impact of the election on fiscal policy before making a decision,\" said Christopher Low, chief economist at FHN Financial.</p><p><div><img src=\"http://k.sinaimg.cn/n/finance/transform/664/w447h217/20201102/c21a-kcieyvz4277219.png/w720fin.jpg\"/></div>In the survey, 59% of economists said they did not expect the Fed to increase its bond purchases by the end of 2021, and few expected policy adjustments at the November meeting.</p><p>Bond Purchase Scheme</p><p>The Fed currently buys $80 billion in U.S. Treasury Bond and $40 billion in mortgage-backed securities each month to help the market run smoothly and put downward pressure on the borrowing rates that households and businesses bear.</p><p><div><img src=\"http://k.sinaimg.cn/n/finance/transform/721/w455h266/20201102/cdff-kcieyvz4277843.png/w720fin.jpg\"/></div>\"The baseline scenario assumes that the U.S. economy will stay on track and there is no need to increase purchases,\" said Roberto Perli, a partner at Cornerstone Macro. \"But if things get worse, I think the Fed will quickly increase its purchases.\"</p><p>Of those who expect the Fed to expand its bond purchases, two-thirds expect it to be in the first quarter of 2021.</p><p>When asked if the Fed would have a meaningful impact on the economy if it increased its debt purchases significantly, only 24% said so.</p><p>Economists strongly oppose the idea that the Fed could shift its buying mix more heavily toward Treasury Bond. In contrast, 61% expect the Fed to eventually change the maturity distribution of bond purchases in favor of longer-maturity bonds. Their current bond purchase operations are roughly balanced and spread across maturities.</p><p>Of the economists who expect the Fed to adjust the maturity of the bonds they buy, 79% expect it to be implemented in December or the first quarter of next year.</p><p></body></html></p>\n<div class=\"bt-text\">\n\n\n<p> source：<a href=\"http://cj.sina.cn/article/normal_detail?url=https://finance.sina.com.cn/stock/usstock/c/2020-11-02/doc-iiznezxr9355664.shtml\">新浪财经</a></p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/0f9e9a265cb0e7e8cb195039b2fe24a4","relate_stocks":{"161125":"标普500","513500":"标普500ETF博时","DDM":"2倍做多道指ETF-ProShares","QQQ":"纳指100ETF","QLD":"2倍做多纳斯达克100指数ETF-ProShares","IVV":"标普500ETF-iShares","SDS":"两倍做空标普500 ETF-ProShares","SPY":"标普500ETF","DJX":"1/100道琼斯","OEX":"标普100","SDOW":"三倍做空道指30ETF-ProShares","QID":"两倍做空纳斯达克指数ETF-ProShares","UDOW":"三倍做多道指30ETF-ProShares","SH":"做空标普500-Proshares","PSQ":"做空纳斯达克100指数ETF-ProShares",".DJI":"道琼斯",".IXIC":"NASDAQ Composite","SPXU":"三倍做空标普500ETF-ProShares","DOG":"道指ETF-ProShares做空","UPRO":"三倍做多标普500ETF-ProShares","SQQQ":"纳指三倍做空ETF","SSO":"2倍做多标普500ETF-ProShares",".SPX":"S&P 500 Index","DXD":"两倍做空道琼30指数ETF-ProShares","TQQQ":"纳指三倍做多ETF","OEF":"标普100指数ETF-iShares"},"source_url":"http://cj.sina.cn/article/normal_detail?url=https://finance.sina.com.cn/stock/usstock/c/2020-11-02/doc-iiznezxr9355664.shtml","is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2080604888","content_text":"彭博调查的经济学家大多认为，美联储今年或明年都不会加快资产购买速度，而即便美联储扩大购债，也不会对美国经济构成富有意义的提振。许多美联储观察人士希望得到关于央行资产负债表政策的更多前瞻指引，但预计联邦公开市场委员会11月4-5日会议不会给出任何新线索。9月15-16日会议后，美联储进一步明确了未来几年的利率路径，但对是否可能改变购债计划的规模或模式，没有任何新指引。彭博于10月23-29日进行的调查显示，54%的受访者称美联储迄今为止都没有“充分描述资产负债表政策并将其与经济目标挂钩”。“除了联邦基金利率将在更长时间维持在近零水平这个强有力的前瞻指引外，货币政策现在高度不透明，”Point Loma Nazarene University首席经济学家Lynn Reaser表示。然而其他受访者表示，在美国大选结果明朗前期待美联储给出新消息，是不公平的。“美联储做决定前必须先观察大选对财政政策的影响，”FHN Financial首席经济学家Christopher Low表示。在这项调查中，59%的经济学家表示预计美联储不会在2021年底前提高购债规模，几乎没人预期11月会议上会有政策调整。购债计划美联储目前每月购买800亿美元的美国国债和400亿美元的抵押贷款支持证券，以帮助市场平稳运行，并对家庭和企业承受的借款利率施加下行压力。“基准情形假设是美国经济将保持在正轨，不需要增加购买量，”Cornerstone Macro合伙人Roberto Perli表示。“但如果情况恶化，我认为美联储将迅速增加购买量。”在预计美联储将扩大购债规模的人当中，三分之二预计会是在2021年第一季度。当被问到若美联储大幅提高购债规模，是否会对经济产生富有意义的影响时，只有24%的人认为会。经济学家强烈反对美联储可能改变购买组合，更多偏重国债的想法。相比之下，61%的人预期美联储将最终改变购买债券的期限分布，更偏重期限较长的债券。他们目前的购债操作大致平衡分散在各个期限上。在预计美联储将调整所购债券期限的经济学家中，79%预计将在12月或明年第一季度实施。","news_type":1,"symbols_score_info":{"161125":0.6,"513500":0.6,"QID":0.6,"SSO":0.6,"SPY":1,"DDM":0.6,"DJX":0.6,"SH":0.6,"PSQ":0.6,"SPXU":0.6,"TQQQ":0.6,".DJI":1,"SDS":0.6,"IVV":0.6,"UDOW":0.6,"OEX":0.6,"OEF":0.6,".IXIC":1,"DOG":0.6,"SDOW":0.6,"QQQ":0.6,"UPRO":0.6,"DXD":0.6,"SQQQ":0.6,".SPX":0.6,"QLD":0.6}},"isVote":1,"tweetType":1,"viewCount":2843,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":306978334,"gmtCreate":1604267335228,"gmtModify":1704955313201,"author":{"id":"3564397746531755","authorId":"3564397746531755","name":"墨池思存","avatar":"https://static.tigerbbs.com/8a9df42be54916e8618a324eb2723690","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3564397746531755","idStr":"3564397746531755"},"themes":[],"htmlText":"?","listText":"?","text":"?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/306978334","repostId":"2080960436","repostType":2,"isVote":1,"tweetType":1,"viewCount":2698,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":301153178,"gmtCreate":1603413927094,"gmtModify":1705072429057,"author":{"id":"3564397746531755","authorId":"3564397746531755","name":"墨池思存","avatar":"https://static.tigerbbs.com/8a9df42be54916e8618a324eb2723690","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3564397746531755","idStr":"3564397746531755"},"themes":[],"htmlText":"?","listText":"?","text":"?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/301153178","repostId":"1156722173","repostType":4,"repost":{"id":"1156722173","kind":"news","weMediaInfo":{"introduction":"为用户提供金融资讯、行情、数据，旨在帮助投资者理解世界，做投资决策。","home_visible":1,"media_name":"老虎资讯综合","id":"102","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1603411964,"share":"https://ttm.financial/m/news/1156722173?lang=en_US&edition=fundamental","pubTime":"2020-10-23 08:12","market":"us","language":"zh","title":"Foreign media headlines: Remdesivir becomes the first drug approved for COVID-19 in the United States","url":"https://stock-news.laohu8.com/highlight/detail?id=1156722173","media":"老虎资讯综合","summary":"彭博社 | 美债收益率攀升银行股引领美股收涨CNBC | 瑞德西韦成为美国首个获批新冠肺炎用药路透社 | 美国单周申请失业救济人数超预期下降；成屋销售量创14年多来新高金融时报 | 高","content":"<p><b>Bloomberg</b> <b>|</b> <b>U.S. bond yields climb, banks lead U.S. stocks to close higher</b><b>CNBC</b> <b>|</b> <b>Remdesivir becomes the first approved drug for COVID-19 in the United States</b><b>REUTERS</b> <b>|</b> <b>U.S. Weekly Unemployment Claims Down More Than Expected; Existing home sales hit a more than 14-year high</b><b>FINANCIAL TIMES</b> <b>|</b> <b>Goldman Sachs Branch Pleads Guilty to Bribery in 1MDB Money Laundering Scandal</b><b>The Wall Street Journal</b> <b>|</b> <b>Walmart preemptively sues U.S. government over opioids</b><h2><b>Bloomberg</b></h2><b>U.S. bond yields climb, banks lead U.S. stocks to close higher</b><img src=\"https://static.tigerbbs.com/fa75092db333f9b4579a7055cff9db8c\" tg-width=\"624\" tg-height=\"486\">Speaker of the U.S. House of Representatives and Democratic leader Pelosi said Thursday that a stimulus agreement with the White House is \"almost\" close, and she is hopeful that a related fiscal spending bill will be reached. U.S. stocks rose in the intraday session, and the three major U.S. stock indexes closed higher collectively. The S&P 500 closed up 0.52%, the Dow closed up 152.84 points, or 0.54%, and the Nasdaq closed up 0.19%.</p><p>U.S. Treasury Bond prices fell on Thursday as yields continued to climb. The yield of 10-year U.S. bonds once rose above 0.87%, a new high since June this year. Thanks to this, U.S. bank stocks rose together, becoming one of the leaders of U.S. stocks that day. Energy stocks also surged as crude oil futures rebounded and emerged from a trough of more than a week. But tech stocks underperformed relatively, with blue-chip tech stock Apple falling nearly 1%.</p><p>While Pelosi has sent a signal of optimism, the Republican-held Senate has remained opposed, reducing the likelihood that Congress will reach a deal before the election in early November.</p><p>European stocks continued to fall on Thursday, with the Stoxx 600 index closing down 0.14%, hitting another closing low in nearly four weeks. Among individual stocks, luxury goods giant Hermes closed up more than 1.6%. Hermes' third-quarter sales performance was better than analysts' expectations due to the pick-up in demand in Asian markets.</p><p><h2><b>CNBC</b></h2><b>Remdesivir becomes the first approved drug for COVID-19 in the United States</b><img src=\"https://static.tigerbbs.com/d356071a0bb64385c52d6b5e61fec958\" tg-width=\"578\" tg-height=\"477\">Gilead Sciences, an American biotechnology company, announced that the U.S. Food and Drug Administration (FDA) approved that its antiviral drug remdesivir can be used to treat COVID-19. The patient should be at least 12 years old and need hospitalization. After the announcement of this news, Gilead Sciences once rose by more than 5% after the market on Thursday. </p><p>Remdesivir became the first and so far the only COVID-19 drug approved by U.S. regulators. In May, the FDA granted it emergency use authority, allowing hospitals and doctors to use it on inpatients. The drug, which has helped shorten the recovery time of some hospitalized patients, was one of the drugs used after Trump was infected earlier this month.</p><p><h2><b>REUTERS</b></h2><b>U.S. Weekly Unemployment Claims Down More Than Expected; Existing home sales hit a more than 14-year high</b> <img src=\"https://static.tigerbbs.com/13fa77f16b63a6345a665f4eaffd0942\" tg-width=\"624\" tg-height=\"495\">The number of first-time unemployment benefits in the United States released by the Labor Department on Thursday was 787,000 last week, down 55,000 from last week, lower than economists' expectation of 860,000 and a new low since early March. Since late September, California, the nation's most populous state, suspended processing data on applications for relief for two weeks, and began to include California's data last week. </p><p>Data shows that the number of initial jobless claims in the United States fell more than expected. The number of applicants reached a record 6.867 million in March. Although it has dropped significantly, it is still well above the peak level of 665,000 during the recession of 2007 to 2009 before the outbreak. This is because the U.S. labor market is showing signs of a tight recovery at a time when the COVID-19 pandemic continues and the impact of fiscal stimulus is fading. </p><p>At least 3.296 million workers applied for extended unemployment benefits in the week ending Oct. 3, an increase of 509,823 from the previous week. Economists say the number of applications for deferred relief due in December is underestimated. The pandemic has hit the U.S. job market unevenly, with unemployment mostly hitting low-income workers. And many high-income employees working from home are driving the growth of the property market. </p><p>Also reported on Thursday, the number of adjusted annualized existing home sales in the United States in September was 6.54 million, a record high since May 2006. However, the strength of the property market is not enough to offset the weakness in other sectors of the economy. The leading indicator in September announced by the Conference Board on the same day increased by 0.7% month-on-month, and the growth rate slowed significantly from 1.4% in August. This is in line with economists' expectations that U.S. GDP growth in the fourth quarter will slow compared with the third quarter.</p><p><h2><b>FINANCIAL TIMES</b></h2><b>Goldman Sachs Branch Pleads Guilty to Bribery in 1MDB Money Laundering Scandal</b><img src=\"https://static.tigerbbs.com/bdd64197a996123ab93f3970a657e056\" tg-width=\"624\" tg-height=\"479\">On Thursday, Karen Seymour, Goldman's chief counsel, said before a federal court judge in New York that Goldman Sachs Malaysia \"pleaded guilty\" to violating U.S. anti-bribery laws in a case related to the money laundering scandal involving 1MDB, a Malaysian government fund, by paying bribes to preserve Goldman's business.</p><p>In order to settle the allegations related to the 1MDB case, Goldman Sachs agreed to pay a total of $2.9 billion to several regulators around the world, including $2.3 billion in fines and $600 million in confiscated Goldman Sachs trading proceeds. These regulators include the US Department of Justice, the US Securities and Exchange Commission, the Federal Reserve, the US Department of Financial Services of the State of New York, the UK Financial Conduct Authority (FCA) and the Prudential Regulatory Authority (PRA), as well as regulators in Malaysia, Singapore and Hong Kong, China.</p><p>It was the first time Goldman Sachs has settled criminal charges since going public, bringing an end to more than four years of regulatory action. As part of the settlement, Goldman Sachs also reached a three-year moratorium on prosecution with the U.S. Department of Justice.</p><p>The settlement announced on Thursday is broadly in line with the amount Goldman Sachs previously provided for possible penalties in the 1MDB case. In July, Goldman Sachs agreed to pay a settlement of $3.9 billion to the Malaysian government.</p><p><h2><b>The Wall Street Journal</b></h2><b>Walmart preemptively sues U.S. government over opioids</b><img src=\"https://static.tigerbbs.com/fcd0a74237127efc8f3ce23b99fda7f3\" tg-width=\"624\" tg-height=\"409\">In anticipation of a civil lawsuit over opioids by the U.S. Justice Department, Wal-Mart preemptively sued the U.S. Justice Department for seeking to make the company a scapegoat and dump the responsibility for what should be the federal government's regulation and crackdown on the opioid crisis on the retail giant.</p><p>In legal filings filed on Thursday, Wal-Mart said the U.S. federal government is seeking large fines for fueling the opioid crisis. The U.S. Department of Justice, Attorney General William Barr, the U.S. Drug Enforcement Administration and its Director Timothy</p><p>Shea's both defendants. Wal-Mart wants the judge to release that the government does not have any legitimate reason to ask the division for civil compensation.</p><p>Walmart operates more than 5,000 brick-and-mortar pharmacies across the United States. The Division believes that the threatening actions of the United States government are unprecedented. The government claims that because pharmacists and pharmacies should have warned about medication when prescribing drugs, it blames Wal-Mart, which sells the drugs. The Department of Justice and the DEA now seek to impose unfeasible requirements on pharmacists and pharmacies that go beyond the qualification requirements for training and licensing in the pharmacist industry.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Foreign media headlines: Remdesivir becomes the first drug approved for COVID-19 in the United States</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nForeign media headlines: Remdesivir becomes the first drug approved for COVID-19 in the United States\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/102\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">老虎资讯综合 </p>\n<p class=\"h-time smaller\">2020-10-23 08:12</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p><b>Bloomberg</b> <b>|</b> <b>U.S. bond yields climb, banks lead U.S. stocks to close higher</b><b>CNBC</b> <b>|</b> <b>Remdesivir becomes the first approved drug for COVID-19 in the United States</b><b>REUTERS</b> <b>|</b> <b>U.S. Weekly Unemployment Claims Down More Than Expected; Existing home sales hit a more than 14-year high</b><b>FINANCIAL TIMES</b> <b>|</b> <b>Goldman Sachs Branch Pleads Guilty to Bribery in 1MDB Money Laundering Scandal</b><b>The Wall Street Journal</b> <b>|</b> <b>Walmart preemptively sues U.S. government over opioids</b><h2><b>Bloomberg</b></h2><b>U.S. bond yields climb, banks lead U.S. stocks to close higher</b><img src=\"https://static.tigerbbs.com/fa75092db333f9b4579a7055cff9db8c\" tg-width=\"624\" tg-height=\"486\">Speaker of the U.S. House of Representatives and Democratic leader Pelosi said Thursday that a stimulus agreement with the White House is \"almost\" close, and she is hopeful that a related fiscal spending bill will be reached. U.S. stocks rose in the intraday session, and the three major U.S. stock indexes closed higher collectively. The S&P 500 closed up 0.52%, the Dow closed up 152.84 points, or 0.54%, and the Nasdaq closed up 0.19%.</p><p>U.S. Treasury Bond prices fell on Thursday as yields continued to climb. The yield of 10-year U.S. bonds once rose above 0.87%, a new high since June this year. Thanks to this, U.S. bank stocks rose together, becoming one of the leaders of U.S. stocks that day. Energy stocks also surged as crude oil futures rebounded and emerged from a trough of more than a week. But tech stocks underperformed relatively, with blue-chip tech stock Apple falling nearly 1%.</p><p>While Pelosi has sent a signal of optimism, the Republican-held Senate has remained opposed, reducing the likelihood that Congress will reach a deal before the election in early November.</p><p>European stocks continued to fall on Thursday, with the Stoxx 600 index closing down 0.14%, hitting another closing low in nearly four weeks. Among individual stocks, luxury goods giant Hermes closed up more than 1.6%. Hermes' third-quarter sales performance was better than analysts' expectations due to the pick-up in demand in Asian markets.</p><p><h2><b>CNBC</b></h2><b>Remdesivir becomes the first approved drug for COVID-19 in the United States</b><img src=\"https://static.tigerbbs.com/d356071a0bb64385c52d6b5e61fec958\" tg-width=\"578\" tg-height=\"477\">Gilead Sciences, an American biotechnology company, announced that the U.S. Food and Drug Administration (FDA) approved that its antiviral drug remdesivir can be used to treat COVID-19. The patient should be at least 12 years old and need hospitalization. After the announcement of this news, Gilead Sciences once rose by more than 5% after the market on Thursday. </p><p>Remdesivir became the first and so far the only COVID-19 drug approved by U.S. regulators. In May, the FDA granted it emergency use authority, allowing hospitals and doctors to use it on inpatients. The drug, which has helped shorten the recovery time of some hospitalized patients, was one of the drugs used after Trump was infected earlier this month.</p><p><h2><b>REUTERS</b></h2><b>U.S. Weekly Unemployment Claims Down More Than Expected; Existing home sales hit a more than 14-year high</b> <img src=\"https://static.tigerbbs.com/13fa77f16b63a6345a665f4eaffd0942\" tg-width=\"624\" tg-height=\"495\">The number of first-time unemployment benefits in the United States released by the Labor Department on Thursday was 787,000 last week, down 55,000 from last week, lower than economists' expectation of 860,000 and a new low since early March. Since late September, California, the nation's most populous state, suspended processing data on applications for relief for two weeks, and began to include California's data last week. </p><p>Data shows that the number of initial jobless claims in the United States fell more than expected. The number of applicants reached a record 6.867 million in March. Although it has dropped significantly, it is still well above the peak level of 665,000 during the recession of 2007 to 2009 before the outbreak. This is because the U.S. labor market is showing signs of a tight recovery at a time when the COVID-19 pandemic continues and the impact of fiscal stimulus is fading. </p><p>At least 3.296 million workers applied for extended unemployment benefits in the week ending Oct. 3, an increase of 509,823 from the previous week. Economists say the number of applications for deferred relief due in December is underestimated. The pandemic has hit the U.S. job market unevenly, with unemployment mostly hitting low-income workers. And many high-income employees working from home are driving the growth of the property market. </p><p>Also reported on Thursday, the number of adjusted annualized existing home sales in the United States in September was 6.54 million, a record high since May 2006. However, the strength of the property market is not enough to offset the weakness in other sectors of the economy. The leading indicator in September announced by the Conference Board on the same day increased by 0.7% month-on-month, and the growth rate slowed significantly from 1.4% in August. This is in line with economists' expectations that U.S. GDP growth in the fourth quarter will slow compared with the third quarter.</p><p><h2><b>FINANCIAL TIMES</b></h2><b>Goldman Sachs Branch Pleads Guilty to Bribery in 1MDB Money Laundering Scandal</b><img src=\"https://static.tigerbbs.com/bdd64197a996123ab93f3970a657e056\" tg-width=\"624\" tg-height=\"479\">On Thursday, Karen Seymour, Goldman's chief counsel, said before a federal court judge in New York that Goldman Sachs Malaysia \"pleaded guilty\" to violating U.S. anti-bribery laws in a case related to the money laundering scandal involving 1MDB, a Malaysian government fund, by paying bribes to preserve Goldman's business.</p><p>In order to settle the allegations related to the 1MDB case, Goldman Sachs agreed to pay a total of $2.9 billion to several regulators around the world, including $2.3 billion in fines and $600 million in confiscated Goldman Sachs trading proceeds. These regulators include the US Department of Justice, the US Securities and Exchange Commission, the Federal Reserve, the US Department of Financial Services of the State of New York, the UK Financial Conduct Authority (FCA) and the Prudential Regulatory Authority (PRA), as well as regulators in Malaysia, Singapore and Hong Kong, China.</p><p>It was the first time Goldman Sachs has settled criminal charges since going public, bringing an end to more than four years of regulatory action. As part of the settlement, Goldman Sachs also reached a three-year moratorium on prosecution with the U.S. Department of Justice.</p><p>The settlement announced on Thursday is broadly in line with the amount Goldman Sachs previously provided for possible penalties in the 1MDB case. In July, Goldman Sachs agreed to pay a settlement of $3.9 billion to the Malaysian government.</p><p><h2><b>The Wall Street Journal</b></h2><b>Walmart preemptively sues U.S. government over opioids</b><img src=\"https://static.tigerbbs.com/fcd0a74237127efc8f3ce23b99fda7f3\" tg-width=\"624\" tg-height=\"409\">In anticipation of a civil lawsuit over opioids by the U.S. Justice Department, Wal-Mart preemptively sued the U.S. Justice Department for seeking to make the company a scapegoat and dump the responsibility for what should be the federal government's regulation and crackdown on the opioid crisis on the retail giant.</p><p>In legal filings filed on Thursday, Wal-Mart said the U.S. federal government is seeking large fines for fueling the opioid crisis. The U.S. Department of Justice, Attorney General William Barr, the U.S. Drug Enforcement Administration and its Director Timothy</p><p>Shea's both defendants. Wal-Mart wants the judge to release that the government does not have any legitimate reason to ask the division for civil compensation.</p><p>Walmart operates more than 5,000 brick-and-mortar pharmacies across the United States. The Division believes that the threatening actions of the United States government are unprecedented. The government claims that because pharmacists and pharmacies should have warned about medication when prescribing drugs, it blames Wal-Mart, which sells the drugs. The Department of Justice and the DEA now seek to impose unfeasible requirements on pharmacists and pharmacies that go beyond the qualification requirements for training and licensing in the pharmacist industry.</p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/c8c31828339b32587d65bd36b68f9023","relate_stocks":{},"is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1156722173","content_text":"彭博社 | 美债收益率攀升银行股引领美股收涨CNBC | 瑞德西韦成为美国首个获批新冠肺炎用药路透社 | 美国单周申请失业救济人数超预期下降；成屋销售量创14年多来新高金融时报 | 高盛分公司认罪承认卷入1MDB洗钱丑闻行贿华尔街日报 | 沃尔玛先发制人就阿片类药物问题起诉美国政府彭博社美债收益率攀升银行股引领美股收涨美国众议院议长、民主党领袖佩洛西周四称，同白宫“差不多”将要达成刺激计划协议，她对达成相关财政支出议案抱有希望。美股盘中转涨，三大美股指集体收涨。标普500收涨0.52%，道指收涨152.84点，涨幅0.54%，纳指收涨0.19%。周四美国国债价格下跌，收益率继续攀升。10年期美债收益率一度升破0.87%，创今年6月以来新高。得益于此，美国银行股齐涨，成为当天美股的领头羊之一。由于原油期货反弹，走出逾一周低谷，能源股也大涨。但科技股相对表现逊色，蓝筹科技股苹果跌近1%。虽然佩洛西释放了乐观信号，但共和党人把持的参议院还持反对态度，这让美国国会在11月初大选前达成协议的可能下降。欧股周四继续下跌，欧洲斯托克600指数收跌0.14%，再创将近四周来收盘新低。个股中，奢侈品巨头爱马仕收涨逾1.6%。因亚洲市场的需求回升，爱马仕的三季度销售业绩优于分析师预期。CNBC瑞德西韦成为美国首个获批新冠肺炎用药美国生物科技公司吉利德科学公布，美国食药监局（FDA）批准，该司的抗病毒药物瑞德西韦可用于治疗新冠肺炎，患者年龄应至少12岁，并且是需要住院治疗的病人。公布这一消息后，吉利德科学周四盘后一度涨超5%。 瑞德西韦成为第一例、也是迄今为止唯一一种美国监管方批准的新冠肺炎用药。今年5月，FDA授予其紧急使用权，允许医院和医生对住院病人使用。此药已经帮助缩短了一些住院病人的康复时间，是本月稍早特朗普被感染后的用药之一。路透社美国单周申请失业救济人数超预期下降；成屋销售量创14年多来新高 美国劳工部周四公布的上周美国首次失业救济人数为78.7万，较上上周减少5.5万，低于经济学家预期的86万，创3月初以来新低。从9月末起，美国人口最多的州加州暂停两周处理申请救济数据，上周开始纳入加州的数据。 数据显示，美国的首次申请失业救济人数超预期下降。3月申请人数曾达到创纪录的686.7万，目前虽然明显回落，但仍远高于疫情爆发前2007年到2009年经济衰退期的巅峰水平66.5万。这是因为，在新冠肺炎疫情持续、财政刺激影响消退之时，美国劳动力市场显示出复苏吃紧的迹象。 截至10月3日一周，至少有329.6万劳动者申请延长失业救济，较此前一周增加50.9823万人。经济学家称，12月到期的延期救济申请人数被低估了。 疫情对美国就业市场的打击并不均衡，失业大多打击到低收入劳动者。而不少在家工作的高收入就业者正在推动楼市增长。 同在周四公布的9月美国调整后成屋年化销售户数为654万，创2006年5月以来新高。不过，楼市的强劲还不足以抵消其他经济领域的疲软。美国谘商会同日公布的9月领先指标环比增长0.7%，增速较8月的1.4%明显放缓。这与经济学家对美国四季度GDP将较三季度增长放缓的预期一致。金融时报高盛分公司认罪承认卷入1MDB洗钱丑闻行贿本周四，高盛的首席法律顾问Karen Seymour在纽约的联邦法院的法官表示，高盛马来西亚分公司“认罪”，承认在马来西亚政府基金1MDB洗钱丑闻的相关案件中，该司违反了美国反行贿法律，为了保住高盛的业务，曾经行贿。为了就1MDB案相关指控达成和解，高盛同意向全球多家监管方支付合计29亿美元，其中包括23亿美元罚款和6亿美元收缴的高盛交易所得。这些监管机构包括美国司法部、美国证监会、美联储、美国纽约州金融服务部、英国金融行为监管局（FCA）和审慎监管局（PRA），还有马来西亚、新加坡和中国香港的监管机构。这是高盛公开上市以来首次就刑事指控达成和解，持续四年多的监管机构行动画上句号。作为和解的部分内容，高盛还同美国司法部达成了为期三年的暂缓起诉协议。本周四公布的和解金和高盛此前为1MDB案可能面临的惩罚所拨备的金额大体一致。今年7月，高盛已经同意，向马来西亚政府支付39亿美元的和解金。华尔街日报沃尔玛先发制人就阿片类药物问题起诉美国政府在预计到美国司法部会就阿片类药物问题提起民事诉讼以前，沃尔玛抢先行动，状告美国司法部寻求让该公司成为替罪羊，将本该是由美国联邦政府监管和打击阿片类用药危机的责任甩给这家零售巨头。在本周四递交的法律文件中，沃尔玛称，美国联邦政府寻求以助长阿片类药物危机为由，该司处以大笔罚款。美国司法部、司法部长William Barr、美国缉毒局及其局长TimothyShea都是被告。沃尔玛希望法官公布，政府没有任何要求该司做出民事赔偿的合法理由。沃尔玛在全美经营5000多家实体药店。该司认为，美国政府的威胁行动是史无前例的。政府声称，因为药剂师和药房在开处方药时本应该对用药提出警告，所以归咎于出售药品的沃尔玛。司法部和缉毒局现在寻求给药剂师和药房施加不可行的要求，超出了药剂师行业培训和持牌的资质要求。","news_type":1,"symbols_score_info":{}},"isVote":1,"tweetType":1,"viewCount":2540,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":301153178,"gmtCreate":1603413927094,"gmtModify":1705072429057,"author":{"id":"3564397746531755","authorId":"3564397746531755","name":"墨池思存","avatar":"https://static.tigerbbs.com/8a9df42be54916e8618a324eb2723690","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3564397746531755","idStr":"3564397746531755"},"themes":[],"htmlText":"?","listText":"?","text":"?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/301153178","repostId":"1156722173","repostType":4,"repost":{"id":"1156722173","kind":"news","weMediaInfo":{"introduction":"为用户提供金融资讯、行情、数据，旨在帮助投资者理解世界，做投资决策。","home_visible":1,"media_name":"老虎资讯综合","id":"102","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1603411964,"share":"https://ttm.financial/m/news/1156722173?lang=en_US&edition=fundamental","pubTime":"2020-10-23 08:12","market":"us","language":"zh","title":"Foreign media headlines: Remdesivir becomes the first drug approved for COVID-19 in the United States","url":"https://stock-news.laohu8.com/highlight/detail?id=1156722173","media":"老虎资讯综合","summary":"彭博社 | 美债收益率攀升银行股引领美股收涨CNBC | 瑞德西韦成为美国首个获批新冠肺炎用药路透社 | 美国单周申请失业救济人数超预期下降；成屋销售量创14年多来新高金融时报 | 高","content":"<p><b>Bloomberg</b> <b>|</b> <b>U.S. bond yields climb, banks lead U.S. stocks to close higher</b><b>CNBC</b> <b>|</b> <b>Remdesivir becomes the first approved drug for COVID-19 in the United States</b><b>REUTERS</b> <b>|</b> <b>U.S. Weekly Unemployment Claims Down More Than Expected; Existing home sales hit a more than 14-year high</b><b>FINANCIAL TIMES</b> <b>|</b> <b>Goldman Sachs Branch Pleads Guilty to Bribery in 1MDB Money Laundering Scandal</b><b>The Wall Street Journal</b> <b>|</b> <b>Walmart preemptively sues U.S. government over opioids</b><h2><b>Bloomberg</b></h2><b>U.S. bond yields climb, banks lead U.S. stocks to close higher</b><img src=\"https://static.tigerbbs.com/fa75092db333f9b4579a7055cff9db8c\" tg-width=\"624\" tg-height=\"486\">Speaker of the U.S. House of Representatives and Democratic leader Pelosi said Thursday that a stimulus agreement with the White House is \"almost\" close, and she is hopeful that a related fiscal spending bill will be reached. U.S. stocks rose in the intraday session, and the three major U.S. stock indexes closed higher collectively. The S&P 500 closed up 0.52%, the Dow closed up 152.84 points, or 0.54%, and the Nasdaq closed up 0.19%.</p><p>U.S. Treasury Bond prices fell on Thursday as yields continued to climb. The yield of 10-year U.S. bonds once rose above 0.87%, a new high since June this year. Thanks to this, U.S. bank stocks rose together, becoming one of the leaders of U.S. stocks that day. Energy stocks also surged as crude oil futures rebounded and emerged from a trough of more than a week. But tech stocks underperformed relatively, with blue-chip tech stock Apple falling nearly 1%.</p><p>While Pelosi has sent a signal of optimism, the Republican-held Senate has remained opposed, reducing the likelihood that Congress will reach a deal before the election in early November.</p><p>European stocks continued to fall on Thursday, with the Stoxx 600 index closing down 0.14%, hitting another closing low in nearly four weeks. Among individual stocks, luxury goods giant Hermes closed up more than 1.6%. Hermes' third-quarter sales performance was better than analysts' expectations due to the pick-up in demand in Asian markets.</p><p><h2><b>CNBC</b></h2><b>Remdesivir becomes the first approved drug for COVID-19 in the United States</b><img src=\"https://static.tigerbbs.com/d356071a0bb64385c52d6b5e61fec958\" tg-width=\"578\" tg-height=\"477\">Gilead Sciences, an American biotechnology company, announced that the U.S. Food and Drug Administration (FDA) approved that its antiviral drug remdesivir can be used to treat COVID-19. The patient should be at least 12 years old and need hospitalization. After the announcement of this news, Gilead Sciences once rose by more than 5% after the market on Thursday. </p><p>Remdesivir became the first and so far the only COVID-19 drug approved by U.S. regulators. In May, the FDA granted it emergency use authority, allowing hospitals and doctors to use it on inpatients. The drug, which has helped shorten the recovery time of some hospitalized patients, was one of the drugs used after Trump was infected earlier this month.</p><p><h2><b>REUTERS</b></h2><b>U.S. Weekly Unemployment Claims Down More Than Expected; Existing home sales hit a more than 14-year high</b> <img src=\"https://static.tigerbbs.com/13fa77f16b63a6345a665f4eaffd0942\" tg-width=\"624\" tg-height=\"495\">The number of first-time unemployment benefits in the United States released by the Labor Department on Thursday was 787,000 last week, down 55,000 from last week, lower than economists' expectation of 860,000 and a new low since early March. Since late September, California, the nation's most populous state, suspended processing data on applications for relief for two weeks, and began to include California's data last week. </p><p>Data shows that the number of initial jobless claims in the United States fell more than expected. The number of applicants reached a record 6.867 million in March. Although it has dropped significantly, it is still well above the peak level of 665,000 during the recession of 2007 to 2009 before the outbreak. This is because the U.S. labor market is showing signs of a tight recovery at a time when the COVID-19 pandemic continues and the impact of fiscal stimulus is fading. </p><p>At least 3.296 million workers applied for extended unemployment benefits in the week ending Oct. 3, an increase of 509,823 from the previous week. Economists say the number of applications for deferred relief due in December is underestimated. The pandemic has hit the U.S. job market unevenly, with unemployment mostly hitting low-income workers. And many high-income employees working from home are driving the growth of the property market. </p><p>Also reported on Thursday, the number of adjusted annualized existing home sales in the United States in September was 6.54 million, a record high since May 2006. However, the strength of the property market is not enough to offset the weakness in other sectors of the economy. The leading indicator in September announced by the Conference Board on the same day increased by 0.7% month-on-month, and the growth rate slowed significantly from 1.4% in August. This is in line with economists' expectations that U.S. GDP growth in the fourth quarter will slow compared with the third quarter.</p><p><h2><b>FINANCIAL TIMES</b></h2><b>Goldman Sachs Branch Pleads Guilty to Bribery in 1MDB Money Laundering Scandal</b><img src=\"https://static.tigerbbs.com/bdd64197a996123ab93f3970a657e056\" tg-width=\"624\" tg-height=\"479\">On Thursday, Karen Seymour, Goldman's chief counsel, said before a federal court judge in New York that Goldman Sachs Malaysia \"pleaded guilty\" to violating U.S. anti-bribery laws in a case related to the money laundering scandal involving 1MDB, a Malaysian government fund, by paying bribes to preserve Goldman's business.</p><p>In order to settle the allegations related to the 1MDB case, Goldman Sachs agreed to pay a total of $2.9 billion to several regulators around the world, including $2.3 billion in fines and $600 million in confiscated Goldman Sachs trading proceeds. These regulators include the US Department of Justice, the US Securities and Exchange Commission, the Federal Reserve, the US Department of Financial Services of the State of New York, the UK Financial Conduct Authority (FCA) and the Prudential Regulatory Authority (PRA), as well as regulators in Malaysia, Singapore and Hong Kong, China.</p><p>It was the first time Goldman Sachs has settled criminal charges since going public, bringing an end to more than four years of regulatory action. As part of the settlement, Goldman Sachs also reached a three-year moratorium on prosecution with the U.S. Department of Justice.</p><p>The settlement announced on Thursday is broadly in line with the amount Goldman Sachs previously provided for possible penalties in the 1MDB case. In July, Goldman Sachs agreed to pay a settlement of $3.9 billion to the Malaysian government.</p><p><h2><b>The Wall Street Journal</b></h2><b>Walmart preemptively sues U.S. government over opioids</b><img src=\"https://static.tigerbbs.com/fcd0a74237127efc8f3ce23b99fda7f3\" tg-width=\"624\" tg-height=\"409\">In anticipation of a civil lawsuit over opioids by the U.S. Justice Department, Wal-Mart preemptively sued the U.S. Justice Department for seeking to make the company a scapegoat and dump the responsibility for what should be the federal government's regulation and crackdown on the opioid crisis on the retail giant.</p><p>In legal filings filed on Thursday, Wal-Mart said the U.S. federal government is seeking large fines for fueling the opioid crisis. The U.S. Department of Justice, Attorney General William Barr, the U.S. Drug Enforcement Administration and its Director Timothy</p><p>Shea's both defendants. Wal-Mart wants the judge to release that the government does not have any legitimate reason to ask the division for civil compensation.</p><p>Walmart operates more than 5,000 brick-and-mortar pharmacies across the United States. The Division believes that the threatening actions of the United States government are unprecedented. The government claims that because pharmacists and pharmacies should have warned about medication when prescribing drugs, it blames Wal-Mart, which sells the drugs. The Department of Justice and the DEA now seek to impose unfeasible requirements on pharmacists and pharmacies that go beyond the qualification requirements for training and licensing in the pharmacist industry.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Foreign media headlines: Remdesivir becomes the first drug approved for COVID-19 in the United States</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nForeign media headlines: Remdesivir becomes the first drug approved for COVID-19 in the United States\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/102\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">老虎资讯综合 </p>\n<p class=\"h-time smaller\">2020-10-23 08:12</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p><b>Bloomberg</b> <b>|</b> <b>U.S. bond yields climb, banks lead U.S. stocks to close higher</b><b>CNBC</b> <b>|</b> <b>Remdesivir becomes the first approved drug for COVID-19 in the United States</b><b>REUTERS</b> <b>|</b> <b>U.S. Weekly Unemployment Claims Down More Than Expected; Existing home sales hit a more than 14-year high</b><b>FINANCIAL TIMES</b> <b>|</b> <b>Goldman Sachs Branch Pleads Guilty to Bribery in 1MDB Money Laundering Scandal</b><b>The Wall Street Journal</b> <b>|</b> <b>Walmart preemptively sues U.S. government over opioids</b><h2><b>Bloomberg</b></h2><b>U.S. bond yields climb, banks lead U.S. stocks to close higher</b><img src=\"https://static.tigerbbs.com/fa75092db333f9b4579a7055cff9db8c\" tg-width=\"624\" tg-height=\"486\">Speaker of the U.S. House of Representatives and Democratic leader Pelosi said Thursday that a stimulus agreement with the White House is \"almost\" close, and she is hopeful that a related fiscal spending bill will be reached. U.S. stocks rose in the intraday session, and the three major U.S. stock indexes closed higher collectively. The S&P 500 closed up 0.52%, the Dow closed up 152.84 points, or 0.54%, and the Nasdaq closed up 0.19%.</p><p>U.S. Treasury Bond prices fell on Thursday as yields continued to climb. The yield of 10-year U.S. bonds once rose above 0.87%, a new high since June this year. Thanks to this, U.S. bank stocks rose together, becoming one of the leaders of U.S. stocks that day. Energy stocks also surged as crude oil futures rebounded and emerged from a trough of more than a week. But tech stocks underperformed relatively, with blue-chip tech stock Apple falling nearly 1%.</p><p>While Pelosi has sent a signal of optimism, the Republican-held Senate has remained opposed, reducing the likelihood that Congress will reach a deal before the election in early November.</p><p>European stocks continued to fall on Thursday, with the Stoxx 600 index closing down 0.14%, hitting another closing low in nearly four weeks. Among individual stocks, luxury goods giant Hermes closed up more than 1.6%. Hermes' third-quarter sales performance was better than analysts' expectations due to the pick-up in demand in Asian markets.</p><p><h2><b>CNBC</b></h2><b>Remdesivir becomes the first approved drug for COVID-19 in the United States</b><img src=\"https://static.tigerbbs.com/d356071a0bb64385c52d6b5e61fec958\" tg-width=\"578\" tg-height=\"477\">Gilead Sciences, an American biotechnology company, announced that the U.S. Food and Drug Administration (FDA) approved that its antiviral drug remdesivir can be used to treat COVID-19. The patient should be at least 12 years old and need hospitalization. After the announcement of this news, Gilead Sciences once rose by more than 5% after the market on Thursday. </p><p>Remdesivir became the first and so far the only COVID-19 drug approved by U.S. regulators. In May, the FDA granted it emergency use authority, allowing hospitals and doctors to use it on inpatients. The drug, which has helped shorten the recovery time of some hospitalized patients, was one of the drugs used after Trump was infected earlier this month.</p><p><h2><b>REUTERS</b></h2><b>U.S. Weekly Unemployment Claims Down More Than Expected; Existing home sales hit a more than 14-year high</b> <img src=\"https://static.tigerbbs.com/13fa77f16b63a6345a665f4eaffd0942\" tg-width=\"624\" tg-height=\"495\">The number of first-time unemployment benefits in the United States released by the Labor Department on Thursday was 787,000 last week, down 55,000 from last week, lower than economists' expectation of 860,000 and a new low since early March. Since late September, California, the nation's most populous state, suspended processing data on applications for relief for two weeks, and began to include California's data last week. </p><p>Data shows that the number of initial jobless claims in the United States fell more than expected. The number of applicants reached a record 6.867 million in March. Although it has dropped significantly, it is still well above the peak level of 665,000 during the recession of 2007 to 2009 before the outbreak. This is because the U.S. labor market is showing signs of a tight recovery at a time when the COVID-19 pandemic continues and the impact of fiscal stimulus is fading. </p><p>At least 3.296 million workers applied for extended unemployment benefits in the week ending Oct. 3, an increase of 509,823 from the previous week. Economists say the number of applications for deferred relief due in December is underestimated. The pandemic has hit the U.S. job market unevenly, with unemployment mostly hitting low-income workers. And many high-income employees working from home are driving the growth of the property market. </p><p>Also reported on Thursday, the number of adjusted annualized existing home sales in the United States in September was 6.54 million, a record high since May 2006. However, the strength of the property market is not enough to offset the weakness in other sectors of the economy. The leading indicator in September announced by the Conference Board on the same day increased by 0.7% month-on-month, and the growth rate slowed significantly from 1.4% in August. This is in line with economists' expectations that U.S. GDP growth in the fourth quarter will slow compared with the third quarter.</p><p><h2><b>FINANCIAL TIMES</b></h2><b>Goldman Sachs Branch Pleads Guilty to Bribery in 1MDB Money Laundering Scandal</b><img src=\"https://static.tigerbbs.com/bdd64197a996123ab93f3970a657e056\" tg-width=\"624\" tg-height=\"479\">On Thursday, Karen Seymour, Goldman's chief counsel, said before a federal court judge in New York that Goldman Sachs Malaysia \"pleaded guilty\" to violating U.S. anti-bribery laws in a case related to the money laundering scandal involving 1MDB, a Malaysian government fund, by paying bribes to preserve Goldman's business.</p><p>In order to settle the allegations related to the 1MDB case, Goldman Sachs agreed to pay a total of $2.9 billion to several regulators around the world, including $2.3 billion in fines and $600 million in confiscated Goldman Sachs trading proceeds. These regulators include the US Department of Justice, the US Securities and Exchange Commission, the Federal Reserve, the US Department of Financial Services of the State of New York, the UK Financial Conduct Authority (FCA) and the Prudential Regulatory Authority (PRA), as well as regulators in Malaysia, Singapore and Hong Kong, China.</p><p>It was the first time Goldman Sachs has settled criminal charges since going public, bringing an end to more than four years of regulatory action. As part of the settlement, Goldman Sachs also reached a three-year moratorium on prosecution with the U.S. Department of Justice.</p><p>The settlement announced on Thursday is broadly in line with the amount Goldman Sachs previously provided for possible penalties in the 1MDB case. In July, Goldman Sachs agreed to pay a settlement of $3.9 billion to the Malaysian government.</p><p><h2><b>The Wall Street Journal</b></h2><b>Walmart preemptively sues U.S. government over opioids</b><img src=\"https://static.tigerbbs.com/fcd0a74237127efc8f3ce23b99fda7f3\" tg-width=\"624\" tg-height=\"409\">In anticipation of a civil lawsuit over opioids by the U.S. Justice Department, Wal-Mart preemptively sued the U.S. Justice Department for seeking to make the company a scapegoat and dump the responsibility for what should be the federal government's regulation and crackdown on the opioid crisis on the retail giant.</p><p>In legal filings filed on Thursday, Wal-Mart said the U.S. federal government is seeking large fines for fueling the opioid crisis. The U.S. Department of Justice, Attorney General William Barr, the U.S. Drug Enforcement Administration and its Director Timothy</p><p>Shea's both defendants. Wal-Mart wants the judge to release that the government does not have any legitimate reason to ask the division for civil compensation.</p><p>Walmart operates more than 5,000 brick-and-mortar pharmacies across the United States. The Division believes that the threatening actions of the United States government are unprecedented. The government claims that because pharmacists and pharmacies should have warned about medication when prescribing drugs, it blames Wal-Mart, which sells the drugs. The Department of Justice and the DEA now seek to impose unfeasible requirements on pharmacists and pharmacies that go beyond the qualification requirements for training and licensing in the pharmacist industry.</p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/c8c31828339b32587d65bd36b68f9023","relate_stocks":{},"is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1156722173","content_text":"彭博社 | 美债收益率攀升银行股引领美股收涨CNBC | 瑞德西韦成为美国首个获批新冠肺炎用药路透社 | 美国单周申请失业救济人数超预期下降；成屋销售量创14年多来新高金融时报 | 高盛分公司认罪承认卷入1MDB洗钱丑闻行贿华尔街日报 | 沃尔玛先发制人就阿片类药物问题起诉美国政府彭博社美债收益率攀升银行股引领美股收涨美国众议院议长、民主党领袖佩洛西周四称，同白宫“差不多”将要达成刺激计划协议，她对达成相关财政支出议案抱有希望。美股盘中转涨，三大美股指集体收涨。标普500收涨0.52%，道指收涨152.84点，涨幅0.54%，纳指收涨0.19%。周四美国国债价格下跌，收益率继续攀升。10年期美债收益率一度升破0.87%，创今年6月以来新高。得益于此，美国银行股齐涨，成为当天美股的领头羊之一。由于原油期货反弹，走出逾一周低谷，能源股也大涨。但科技股相对表现逊色，蓝筹科技股苹果跌近1%。虽然佩洛西释放了乐观信号，但共和党人把持的参议院还持反对态度，这让美国国会在11月初大选前达成协议的可能下降。欧股周四继续下跌，欧洲斯托克600指数收跌0.14%，再创将近四周来收盘新低。个股中，奢侈品巨头爱马仕收涨逾1.6%。因亚洲市场的需求回升，爱马仕的三季度销售业绩优于分析师预期。CNBC瑞德西韦成为美国首个获批新冠肺炎用药美国生物科技公司吉利德科学公布，美国食药监局（FDA）批准，该司的抗病毒药物瑞德西韦可用于治疗新冠肺炎，患者年龄应至少12岁，并且是需要住院治疗的病人。公布这一消息后，吉利德科学周四盘后一度涨超5%。 瑞德西韦成为第一例、也是迄今为止唯一一种美国监管方批准的新冠肺炎用药。今年5月，FDA授予其紧急使用权，允许医院和医生对住院病人使用。此药已经帮助缩短了一些住院病人的康复时间，是本月稍早特朗普被感染后的用药之一。路透社美国单周申请失业救济人数超预期下降；成屋销售量创14年多来新高 美国劳工部周四公布的上周美国首次失业救济人数为78.7万，较上上周减少5.5万，低于经济学家预期的86万，创3月初以来新低。从9月末起，美国人口最多的州加州暂停两周处理申请救济数据，上周开始纳入加州的数据。 数据显示，美国的首次申请失业救济人数超预期下降。3月申请人数曾达到创纪录的686.7万，目前虽然明显回落，但仍远高于疫情爆发前2007年到2009年经济衰退期的巅峰水平66.5万。这是因为，在新冠肺炎疫情持续、财政刺激影响消退之时，美国劳动力市场显示出复苏吃紧的迹象。 截至10月3日一周，至少有329.6万劳动者申请延长失业救济，较此前一周增加50.9823万人。经济学家称，12月到期的延期救济申请人数被低估了。 疫情对美国就业市场的打击并不均衡，失业大多打击到低收入劳动者。而不少在家工作的高收入就业者正在推动楼市增长。 同在周四公布的9月美国调整后成屋年化销售户数为654万，创2006年5月以来新高。不过，楼市的强劲还不足以抵消其他经济领域的疲软。美国谘商会同日公布的9月领先指标环比增长0.7%，增速较8月的1.4%明显放缓。这与经济学家对美国四季度GDP将较三季度增长放缓的预期一致。金融时报高盛分公司认罪承认卷入1MDB洗钱丑闻行贿本周四，高盛的首席法律顾问Karen Seymour在纽约的联邦法院的法官表示，高盛马来西亚分公司“认罪”，承认在马来西亚政府基金1MDB洗钱丑闻的相关案件中，该司违反了美国反行贿法律，为了保住高盛的业务，曾经行贿。为了就1MDB案相关指控达成和解，高盛同意向全球多家监管方支付合计29亿美元，其中包括23亿美元罚款和6亿美元收缴的高盛交易所得。这些监管机构包括美国司法部、美国证监会、美联储、美国纽约州金融服务部、英国金融行为监管局（FCA）和审慎监管局（PRA），还有马来西亚、新加坡和中国香港的监管机构。这是高盛公开上市以来首次就刑事指控达成和解，持续四年多的监管机构行动画上句号。作为和解的部分内容，高盛还同美国司法部达成了为期三年的暂缓起诉协议。本周四公布的和解金和高盛此前为1MDB案可能面临的惩罚所拨备的金额大体一致。今年7月，高盛已经同意，向马来西亚政府支付39亿美元的和解金。华尔街日报沃尔玛先发制人就阿片类药物问题起诉美国政府在预计到美国司法部会就阿片类药物问题提起民事诉讼以前，沃尔玛抢先行动，状告美国司法部寻求让该公司成为替罪羊，将本该是由美国联邦政府监管和打击阿片类用药危机的责任甩给这家零售巨头。在本周四递交的法律文件中，沃尔玛称，美国联邦政府寻求以助长阿片类药物危机为由，该司处以大笔罚款。美国司法部、司法部长William Barr、美国缉毒局及其局长TimothyShea都是被告。沃尔玛希望法官公布，政府没有任何要求该司做出民事赔偿的合法理由。沃尔玛在全美经营5000多家实体药店。该司认为，美国政府的威胁行动是史无前例的。政府声称，因为药剂师和药房在开处方药时本应该对用药提出警告，所以归咎于出售药品的沃尔玛。司法部和缉毒局现在寻求给药剂师和药房施加不可行的要求，超出了药剂师行业培训和持牌的资质要求。","news_type":1,"symbols_score_info":{}},"isVote":1,"tweetType":1,"viewCount":2540,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":306978120,"gmtCreate":1604267765560,"gmtModify":1704955313038,"author":{"id":"3564397746531755","authorId":"3564397746531755","name":"墨池思存","avatar":"https://static.tigerbbs.com/8a9df42be54916e8618a324eb2723690","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3564397746531755","idStr":"3564397746531755"},"themes":[],"htmlText":"?","listText":"?","text":"?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/306978120","repostId":"2080604888","repostType":2,"repost":{"id":"2080604888","kind":"news","pubTimestamp":1604261466,"share":"https://ttm.financial/m/news/2080604888?lang=en_US&edition=fundamental","pubTime":"2020-11-02 04:11","market":"sh","language":"zh","title":"The Federal Reserve is not expected to expand its bond purchases or shift to longer-term bonds this year and next","url":"https://stock-news.laohu8.com/highlight/detail?id=2080604888","media":"新浪财经","summary":"彭博调查的经济学家大多认为，美联储今年或明年都不会加快资产购买速度，而即便美联储扩大购债，也不会对美国经济构成富有意义的提振。在这项调查中，59%的经济学家表示预计美联储不会在2021年底前提高购债规模，几乎没人预期11月会议上会有政策调整。在预计美联储将扩大购债规模的人当中，三分之二预计会是在2021年第一季度。相比之下，61%的人预期美联储将最终改变购买债券的期限分布，更偏重期限较长的债券。","content":"<p><html><body>Most economists surveyed by Bloomberg believe that the Fed will not speed up asset purchases this year or next year, and even if the Fed expands its bond purchases, it will not give a meaningful boost to the U.S. economy.</p><p>Many Fed watchers are hoping for more forward guidance on the central bank's balance sheet policy, but don't expect any new clues from the FOMC Nov. 4-5 meeting. After the September 15-16 meeting, the Fed further clarified the path of interest rates in the coming years, but there was no new guidance on whether it might change the size or pattern of the bond purchase program.</p><p>According to the survey conducted by Bloomberg on Oct. 23-29, 54% of respondents said the Fed has so far failed to \"adequately describe balance sheet policy and link it to economic goals.\"</p><p>\"Aside from strong forward guidance that Federal Funds rate will remain near zero for longer, monetary policy is now highly opaque,\" said Lynn Reaser, chief economist at Point Loma Nazarene University.</p><p>However, other respondents said it was unfair to expect new information from the Fed before the results of the US election were clear.</p><p>\"The Fed must observe the impact of the election on fiscal policy before making a decision,\" said Christopher Low, chief economist at FHN Financial.</p><p><div><img src=\"http://k.sinaimg.cn/n/finance/transform/664/w447h217/20201102/c21a-kcieyvz4277219.png/w720fin.jpg\"/></div>In the survey, 59% of economists said they did not expect the Fed to increase its bond purchases by the end of 2021, and few expected policy adjustments at the November meeting.</p><p>Bond Purchase Scheme</p><p>The Fed currently buys $80 billion in U.S. Treasury Bond and $40 billion in mortgage-backed securities each month to help the market run smoothly and put downward pressure on the borrowing rates that households and businesses bear.</p><p><div><img src=\"http://k.sinaimg.cn/n/finance/transform/721/w455h266/20201102/cdff-kcieyvz4277843.png/w720fin.jpg\"/></div>\"The baseline scenario assumes that the U.S. economy will stay on track and there is no need to increase purchases,\" said Roberto Perli, a partner at Cornerstone Macro. \"But if things get worse, I think the Fed will quickly increase its purchases.\"</p><p>Of those who expect the Fed to expand its bond purchases, two-thirds expect it to be in the first quarter of 2021.</p><p>When asked if the Fed would have a meaningful impact on the economy if it increased its debt purchases significantly, only 24% said so.</p><p>Economists strongly oppose the idea that the Fed could shift its buying mix more heavily toward Treasury Bond. In contrast, 61% expect the Fed to eventually change the maturity distribution of bond purchases in favor of longer-maturity bonds. Their current bond purchase operations are roughly balanced and spread across maturities.</p><p>Of the economists who expect the Fed to adjust the maturity of the bonds they buy, 79% expect it to be implemented in December or the first quarter of next year.</p><p></body></html></p>","source":"sina_symbol","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>The Federal Reserve is not expected to expand its bond purchases or shift to longer-term bonds this year and next</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThe Federal Reserve is not expected to expand its bond purchases or shift to longer-term bonds this year and next\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">新浪财经</strong><span class=\"h-time small\">2020-11-02 04:11</span>\n</p>\n</h4>\n</header>\n<article>\n<p><html><body>Most economists surveyed by Bloomberg believe that the Fed will not speed up asset purchases this year or next year, and even if the Fed expands its bond purchases, it will not give a meaningful boost to the U.S. economy.</p><p>Many Fed watchers are hoping for more forward guidance on the central bank's balance sheet policy, but don't expect any new clues from the FOMC Nov. 4-5 meeting. After the September 15-16 meeting, the Fed further clarified the path of interest rates in the coming years, but there was no new guidance on whether it might change the size or pattern of the bond purchase program.</p><p>According to the survey conducted by Bloomberg on Oct. 23-29, 54% of respondents said the Fed has so far failed to \"adequately describe balance sheet policy and link it to economic goals.\"</p><p>\"Aside from strong forward guidance that Federal Funds rate will remain near zero for longer, monetary policy is now highly opaque,\" said Lynn Reaser, chief economist at Point Loma Nazarene University.</p><p>However, other respondents said it was unfair to expect new information from the Fed before the results of the US election were clear.</p><p>\"The Fed must observe the impact of the election on fiscal policy before making a decision,\" said Christopher Low, chief economist at FHN Financial.</p><p><div><img src=\"http://k.sinaimg.cn/n/finance/transform/664/w447h217/20201102/c21a-kcieyvz4277219.png/w720fin.jpg\"/></div>In the survey, 59% of economists said they did not expect the Fed to increase its bond purchases by the end of 2021, and few expected policy adjustments at the November meeting.</p><p>Bond Purchase Scheme</p><p>The Fed currently buys $80 billion in U.S. Treasury Bond and $40 billion in mortgage-backed securities each month to help the market run smoothly and put downward pressure on the borrowing rates that households and businesses bear.</p><p><div><img src=\"http://k.sinaimg.cn/n/finance/transform/721/w455h266/20201102/cdff-kcieyvz4277843.png/w720fin.jpg\"/></div>\"The baseline scenario assumes that the U.S. economy will stay on track and there is no need to increase purchases,\" said Roberto Perli, a partner at Cornerstone Macro. \"But if things get worse, I think the Fed will quickly increase its purchases.\"</p><p>Of those who expect the Fed to expand its bond purchases, two-thirds expect it to be in the first quarter of 2021.</p><p>When asked if the Fed would have a meaningful impact on the economy if it increased its debt purchases significantly, only 24% said so.</p><p>Economists strongly oppose the idea that the Fed could shift its buying mix more heavily toward Treasury Bond. In contrast, 61% expect the Fed to eventually change the maturity distribution of bond purchases in favor of longer-maturity bonds. Their current bond purchase operations are roughly balanced and spread across maturities.</p><p>Of the economists who expect the Fed to adjust the maturity of the bonds they buy, 79% expect it to be implemented in December or the first quarter of next year.</p><p></body></html></p>\n<div class=\"bt-text\">\n\n\n<p> source：<a href=\"http://cj.sina.cn/article/normal_detail?url=https://finance.sina.com.cn/stock/usstock/c/2020-11-02/doc-iiznezxr9355664.shtml\">新浪财经</a></p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/0f9e9a265cb0e7e8cb195039b2fe24a4","relate_stocks":{"161125":"标普500","513500":"标普500ETF博时","DDM":"2倍做多道指ETF-ProShares","QQQ":"纳指100ETF","QLD":"2倍做多纳斯达克100指数ETF-ProShares","IVV":"标普500ETF-iShares","SDS":"两倍做空标普500 ETF-ProShares","SPY":"标普500ETF","DJX":"1/100道琼斯","OEX":"标普100","SDOW":"三倍做空道指30ETF-ProShares","QID":"两倍做空纳斯达克指数ETF-ProShares","UDOW":"三倍做多道指30ETF-ProShares","SH":"做空标普500-Proshares","PSQ":"做空纳斯达克100指数ETF-ProShares",".DJI":"道琼斯",".IXIC":"NASDAQ Composite","SPXU":"三倍做空标普500ETF-ProShares","DOG":"道指ETF-ProShares做空","UPRO":"三倍做多标普500ETF-ProShares","SQQQ":"纳指三倍做空ETF","SSO":"2倍做多标普500ETF-ProShares",".SPX":"S&P 500 Index","DXD":"两倍做空道琼30指数ETF-ProShares","TQQQ":"纳指三倍做多ETF","OEF":"标普100指数ETF-iShares"},"source_url":"http://cj.sina.cn/article/normal_detail?url=https://finance.sina.com.cn/stock/usstock/c/2020-11-02/doc-iiznezxr9355664.shtml","is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2080604888","content_text":"彭博调查的经济学家大多认为，美联储今年或明年都不会加快资产购买速度，而即便美联储扩大购债，也不会对美国经济构成富有意义的提振。许多美联储观察人士希望得到关于央行资产负债表政策的更多前瞻指引，但预计联邦公开市场委员会11月4-5日会议不会给出任何新线索。9月15-16日会议后，美联储进一步明确了未来几年的利率路径，但对是否可能改变购债计划的规模或模式，没有任何新指引。彭博于10月23-29日进行的调查显示，54%的受访者称美联储迄今为止都没有“充分描述资产负债表政策并将其与经济目标挂钩”。“除了联邦基金利率将在更长时间维持在近零水平这个强有力的前瞻指引外，货币政策现在高度不透明，”Point Loma Nazarene University首席经济学家Lynn Reaser表示。然而其他受访者表示，在美国大选结果明朗前期待美联储给出新消息，是不公平的。“美联储做决定前必须先观察大选对财政政策的影响，”FHN Financial首席经济学家Christopher Low表示。在这项调查中，59%的经济学家表示预计美联储不会在2021年底前提高购债规模，几乎没人预期11月会议上会有政策调整。购债计划美联储目前每月购买800亿美元的美国国债和400亿美元的抵押贷款支持证券，以帮助市场平稳运行，并对家庭和企业承受的借款利率施加下行压力。“基准情形假设是美国经济将保持在正轨，不需要增加购买量，”Cornerstone Macro合伙人Roberto Perli表示。“但如果情况恶化，我认为美联储将迅速增加购买量。”在预计美联储将扩大购债规模的人当中，三分之二预计会是在2021年第一季度。当被问到若美联储大幅提高购债规模，是否会对经济产生富有意义的影响时，只有24%的人认为会。经济学家强烈反对美联储可能改变购买组合，更多偏重国债的想法。相比之下，61%的人预期美联储将最终改变购买债券的期限分布，更偏重期限较长的债券。他们目前的购债操作大致平衡分散在各个期限上。在预计美联储将调整所购债券期限的经济学家中，79%预计将在12月或明年第一季度实施。","news_type":1,"symbols_score_info":{"161125":0.6,"513500":0.6,"QID":0.6,"SSO":0.6,"SPY":1,"DDM":0.6,"DJX":0.6,"SH":0.6,"PSQ":0.6,"SPXU":0.6,"TQQQ":0.6,".DJI":1,"SDS":0.6,"IVV":0.6,"UDOW":0.6,"OEX":0.6,"OEF":0.6,".IXIC":1,"DOG":0.6,"SDOW":0.6,"QQQ":0.6,"UPRO":0.6,"DXD":0.6,"SQQQ":0.6,".SPX":0.6,"QLD":0.6}},"isVote":1,"tweetType":1,"viewCount":2843,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":306978334,"gmtCreate":1604267335228,"gmtModify":1704955313201,"author":{"id":"3564397746531755","authorId":"3564397746531755","name":"墨池思存","avatar":"https://static.tigerbbs.com/8a9df42be54916e8618a324eb2723690","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3564397746531755","idStr":"3564397746531755"},"themes":[],"htmlText":"?","listText":"?","text":"?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/306978334","repostId":"2080960436","repostType":2,"isVote":1,"tweetType":1,"viewCount":2698,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}
